Radar Signals: Prana Biotech (PRAN) Positive Data, Magellan Petroleum

Prana Biotechnology (PRAN)

Huntington's disease is an inherited disease that causes the progressive breakdown (degeneration) of nerve cells in the brain.

Symptoms of Huntington's disease usually develop between ages 30 and 50, but they can appear as early as age 2 or as late as 80.

The hallmark symptom of Huntington's disease is uncontrolled movement of the arms, legs, head, face and upper body. Huntington's disease also causes a decline in thinking and reasoning skills, including memory, concentration, judgment and ability to plan and organize.

PRAN reported that its Phase 2 REACH2HD clinical trial investigating PBT2 as a treatment for Huntington disease met its primary safety endpoint and achieved statistically significant improvement in a measure of executive function (cognition), which comprised part of the study's main efficacy outcome.

PRAN plans to advance PBT2 into a confirmatory Phase 3 clinical trial that could allow PBT2 to be approved for the treatment of Huntington disease.

PRAN is developing first-in-class therapies to treat neurodegenerative disease. PRAN 's lead drug candidate – PBT2 – is being developed for the treatment of Alzheimer’s and Huntington's diseases

More about Prana Biotechnology (PRAN) at www.pranabio.com .

**

Crown Equity Holdings Inc. (CRWE)

Looking to deliver value for its stockholders in both the near and long term, CRWE is currently developing its CRWE Network ( CRWE-PR.com ), a social networking service designed to target all the communities in the U.S. and Canada, which business model is based on selling advertising to local businesses.

CRWE Network’s goal is to facilitate exchanges of goods and services in a manner similar to Craigslist, a classified advertisements website with sections devoted to jobs, housing, personals, for sale, items wanted, services, community, gigs, résumés, and discussion forums, while providing micro community news, information and business directory content.

CRWE-PR has included in its platform a coupon page, giving business owners some flexibility in instantly creating, modifying and publishing promotional deals to consumers of every kind, such as local restaurants, auto repairs, realtors, bars, movie theaters, retailers, golf courses, auto dealerships and any other variety of businesses existing within a community.

CRWE presently has more than 50 cities in its network of community publications.

CRWE provides marketing solutions that boost customer awareness and merchant visibility on the Internet

More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com

**

Magellan Petroleum Corporation (MPET)

MPET said that it has entered into a definitive agreement to sell the Palm Valley and Dingo gas fields to Central Petroleum Limited through the sale of its wholly owned subsidiary Magellan Petroleum (N.T.) Pty. Ltd.

In exchange, Central will pay to MPET a total of AUD $35.0 million (AUD $20.0 million is payable in cash and AUD $15.0 million is payable in Central stock upon transaction completion).

** 1 AUD = 0.9027 USD (source: https://www.google.com/finance?q=AUDUSD )

In addition, MPET will receive bonuses from Central in the event that future gas sales revenues from Palm Valley exceed certain levels.

MPET is an independent oil and gas exploration and development company with assets in the US, Australia, and the UK.

More about Magellan Petroleum Corporation (MPET) at www.magellanpetroleum.com .

**

Nova Measuring Instruments Ltd. (NVMI)

Keep a close eye on NVMI . The company reported record fourth quarter and full year 2013 financial results, exceeding the high end of its quarterly revenue guidance, due to strong demand for the company's Optical Metrology solutions during the quarter.

For the fourth quarter 2013, NVMI posted total revenues of $30.2 million, a 37% increase year over year, GAAP net income of $3.1 million, or $0.11 per diluted share, compared to $2.5 million, or $0.09 per diluted share in the same period the prior year, and Non-GAAP net income of $4.1 million, or $0.15 per diluted share, compared to $1.0 million, or $0.04 per diluted share, in the fourth quarter of 2012

During 2013, NVMI generated $11.0 million in cash flow from operating activities, compared to $7.7 million in 2012.

NVMI develops, produces and markets advanced integrated and stand alone metrology solutions for the semiconductor manufacturing industry.

More about Nova Measuring Instruments Ltd. (NVMI) at www.novameasuring.com

**

Read Full Disclaimer at www.pennyomega.com/disclaimer